Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
US-2026092045-A1 · Apr 2, 2026 · US
Biocryst Pharm Inc holds 129 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 129 |
| Recent patents | 49 |
| First publication | Feb 19, 2015 |
| Latest publication | Apr 2, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026092045-A1 · Apr 2, 2026 · US
US-12590069-B2 · Mar 31, 2026 · US
US-12590068-B2 · Mar 31, 2026 · US
US-12589093-B2 · Mar 31, 2026 · US
US-12558341-B2 · Feb 24, 2026 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026092045-A1 · Apr 2, 2026 · US
US-12590069-B2 · Mar 31, 2026 · US
US-12590068-B2 · Mar 31, 2026 · US
US-12589093-B2 · Mar 31, 2026 · US
US-12558341-B2 · Feb 24, 2026 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 127 |
| Chemistry & Metallurgy | 121 |
| Cross-Sectional Technologies | 28 |
Answers are generated from the same data shown on this page.